Trademark: 90795540
Status Date
Thursday, December 7, 2023
Filing Date
Friday, June 25, 2021
Published for Opposition
Tuesday, November 8, 2022
5 Pharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
Dec 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2023
Sou Extension 2 Granted
Dec 7, 2023
Sou Extension 2 Filed
Dec 7, 2023
Sou Teas Extension Received
Aug 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 1, 2023
Corrected Noa E-Mailed
Jul 31, 2023
Sou Extension 1 Granted
Jun 29, 2023
Sou Extension 1 Filed
Jul 31, 2023
Divisional Processing Complete
Jun 29, 2023
Divisional Request Received
Jul 19, 2023
Case Assigned To Intent To Use Paralegal
Jun 29, 2023
Sou Teas Extension Received
Jun 29, 2023
Teas Request To Divide Received
Jan 3, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 6, 2022
Approved For Pub - Principal Register
Oct 6, 2022
Examiner's Amendment Entered
Oct 6, 2022
Notification Of Examiners Amendment E-Mailed
Oct 6, 2022
Examiners Amendment E-Mailed
Oct 6, 2022
Examiners Amendment -Written
Oct 1, 2022
Teas/Email Correspondence Entered
Sep 30, 2022
Correspondence Received In Law Office
Sep 30, 2022
Teas Response To Office Action Received
Mar 31, 2022
Notification Of Non-Final Action E-Mailed
Mar 31, 2022
Non-Final Action E-Mailed
Mar 31, 2022
Non-Final Action Written
Mar 17, 2022
Assigned To Examiner
Sep 9, 2021
New Application Office Supplied Data Entered
Jun 29, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
